See more : Nova LifeStyle, Inc. (NVFY) Income Statement Analysis – Financial Results
Complete financial analysis of 1933 Industries Inc. (TGIFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 1933 Industries Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Union Bank of India (UNIONBANK.NS) Income Statement Analysis – Financial Results
- Sucro Limited (SUG.V) Income Statement Analysis – Financial Results
- Cencora (0HF3.L) Income Statement Analysis – Financial Results
- Caledonia Mining Corporation Plc (CMCL) Income Statement Analysis – Financial Results
- Seiko Holdings Corporation (8050.T) Income Statement Analysis – Financial Results
1933 Industries Inc. (TGIFF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.1933industries.com
About 1933 Industries Inc.
1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. It operates in the medical and recreational cannabis sectors. The company also offers cannabidiol (CBD) infused products, such as vape pens, cartridges, lotions, lip balms, hemp seed oils, edible products, topical and dietary supplements, cosmetics, tinctures, sauces, vaporizers, drink additives, baking items, sweeteners, capsules, and tetrahydrocannabinol concentrates under the Canna Hemp, Canna Hemp X, Canna Hemp PLUS, Canna Hemp HEMP, and Canna Fused brands. In addition, it provides cannabis flowers and concentrates. 1933 Industries Inc. offers CBD infused products through retail dispensaries, retail outlets, and e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. The company is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.27M | 12.54M | 11.98M | 11.96M | 18.06M | 12.65M | 1.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 173.00 | 409.00 | 2.66K |
| Cost of Revenue | 22.50M | 9.85M | 7.16M | 9.68M | 12.76M | 6.20M | 799.58K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -4.22M | 2.69M | 4.82M | 2.28M | 5.30M | 6.45M | 230.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 173.00 | 409.00 | 2.66K |
| Gross Profit Ratio | -23.12% | 21.46% | 40.25% | 19.10% | 29.33% | 50.99% | 22.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.02M | 6.63M | 7.59M | 14.70M | 13.25M | 8.17M | 2.58M | 3.67M | 40.84K | 92.04K | 84.71K | 153.19K | 478.67K | 151.97K | 61.48K | 32.37K |
| Selling & Marketing | 1.11M | 575.71K | 351.01K | 2.04M | 1.37M | 671.37K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.13M | 7.21M | 7.94M | 16.73M | 14.62M | 8.84M | 2.58M | 3.67M | 40.84K | 92.04K | 84.71K | 153.19K | 478.67K | 151.97K | 61.48K | 32.37K |
| Other Expenses | 0.00 | 193.42K | 298.01K | 185.33K | 0.00 | -565.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | -602.76K | 7.71M | 8.44M | 18.92M | 15.27M | 9.12M | 2.60M | 3.67M | 40.84K | 92.04K | 84.97K | 154.21K | 567.78K | 152.18K | 61.48K | 32.37K |
| Cost & Expenses | 27.62M | 17.56M | 15.60M | 28.60M | 28.03M | 15.32M | 3.40M | 3.67M | 40.84K | 92.04K | 84.97K | 154.21K | 567.78K | 152.18K | 61.48K | 32.37K |
| Interest Income | 0.00 | 16.49K | 2.11M | 3.70M | 2.79M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 173.00 | 409.00 | 0.00 |
| Interest Expense | 1.72M | 1.76M | 2.11M | 3.70M | 2.79M | 842.12K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.69M | 1.92M | 993.31K | 2.19M | 648.97K | 278.61K | 13.53K | 1.70M | 163.37K | -3.50K | 255.00 | 1.02K | 716.00 | 208.00 | 0.00 | 0.00 |
| EBITDA | -10.03M | -2.88M | -2.71M | -14.26M | -9.32M | -2.87M | -2.53M | 0.00 | 0.00 | -95.54K | 860.74K | -95.96K | -567.06K | -151.80K | -61.07K | -29.71K |
| EBITDA Ratio | -54.91% | -23.01% | -19.45% | -120.77% | -51.60% | -23.39% | -228.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -87,742.77% | -14,931.78% | -1,119.06% |
| Operating Income | -9.35M | -4.81M | -3.32M | -16.63M | -9.97M | -3.24M | -2.55M | -3.67M | -40.84K | -92.04K | -1.03M | -211.44K | -567.78K | -152.00K | -61.07K | -29.71K |
| Operating Income Ratio | -51.16% | -38.35% | -27.74% | -139.04% | -55.20% | -25.59% | -247.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -87,863.01% | -14,931.78% | -1,119.06% |
| Total Other Income/Expenses | -4.09M | -12.71M | -2.48M | -3.51M | -9.68M | -1.96M | -193.25K | 0.00 | 0.00 | 3.50K | 0.00 | 0.00 | 0.00 | 0.00 | 61.07K | 29.71K |
| Income Before Tax | -13.44M | -17.52M | -5.81M | -20.15M | -19.65M | -4.31M | -2.55M | -3.67M | -40.84K | -88.54K | -1.03M | -211.44K | -567.78K | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -73.57% | -139.71% | -48.48% | -168.40% | -108.79% | -34.08% | -247.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 515.53K | 549.00K | 482.00K | -128.05K | -1.11M | 1.18M | 67.08K | -3.67M | -163.37K | 0.00 | 945.46K | -55.54K | -3.62K | 0.00 | 61.07K | 29.71K |
| Net Income | -13.36M | -17.81M | -6.47M | -21.54M | -18.79M | -5.84M | -2.73M | -3.67M | -40.84K | -88.54K | -1.03M | -155.90K | -564.16K | -152.00K | -61.07K | -29.71K |
| Net Income Ratio | -73.13% | -142.02% | -54.03% | -180.08% | -104.03% | -46.20% | -265.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -87,863.01% | -14,931.78% | -1,119.06% |
| EPS | -0.03 | -0.04 | -0.02 | -0.08 | -0.07 | -0.03 | -0.06 | -0.21 | -0.01 | -0.05 | -0.67 | -0.12 | -0.47 | -0.29 | -0.61 | -0.58 |
| EPS Diluted | -0.03 | -0.04 | -0.02 | -0.08 | -0.07 | -0.03 | -0.06 | -0.21 | -0.01 | -0.05 | -0.67 | -0.12 | -0.47 | -0.29 | -0.61 | -0.58 |
| Weighted Avg Shares Out | 455.69M | 450.68M | 387.01M | 286.37M | 252.12M | 192.47M | 45.70M | 17.83M | 3.33M | 1.83M | 1.54M | 1.26M | 1.20M | 515.47K | 100.00K | 51.63K |
| Weighted Avg Shares Out (Dil) | 455.69M | 450.68M | 387.01M | 286.37M | 252.12M | 192.47M | 45.70M | 17.83M | 3.33M | 1.83M | 1.54M | 1.26M | 1.20M | 515.47K | 100.00K | 51.63K |
1933 Industries to Trade on the Pink Open Market
VANCOUVER, BC / ACCESSWIRE / October 3, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC Pink:TGIFF), a Nevada-focused cannabis cultivator and producer, announces that its common stock was moved from the OTCQB Market to the OTC Pink...
1933 Industries Announces Board Resignation
VANCOUVER, BC / ACCESSWIRE / September 5, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, announces that Mr. Rick Skeith has tendered his resignation from the Board of Directors effective immediately.
1933 Industries Reports Profit in Q3 2024 Financials
VANCOUVER, BC / ACCESSWIRE / July 2, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its unaudited interim consolidated financial statements for the three and nine months...
1933 Industries Announces Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / June 7, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased...
1933 Industries Extends Expiry Date of Warrants
VANCOUVER, BC / ACCESSWIRE / June 5, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, announces that it reached an agreement to amend the expiry date of its outstanding 3,700,000 warrants...
1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary
VANCOUVER, BC / ACCESSWIRE / April 8, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce that its wholly owned subsidiary, FN Pharmaceuticals, has entered into a Membership...
1933 Industries Pauses CBD Manufacturing Division
VANCOUVER, BC / ACCESSWIRE / March 12, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, announces that it will be suspending its Canna Hemp™ CBD consumer packaged goods subsidiary, as it...
1933 Industries Issues Correction
VANCOUVER, BC / ACCESSWIRE / March 1, 2023 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, announces a correction to its news release dated February 29, 2024. The number issued of New...
1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures
VANCOUVER, BC / ACCESSWIRE / February 29, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce the issuance of a new 10% Senior Unsecured Convertible Debenture (the "New...
1933 Industries Reports First Quarter 2024 Financials and Announces the Issuance of New Debenture
VANCOUVER, BC / ACCESSWIRE / January 2, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its unaudited interim consolidated financial statements for the three months ended October...
Source: https://incomestatements.info
Category: Stock Reports